PD-L1 testing in urothelial carcinoma: are we there yet?

por van Leenders, Geert J. L. H.
Publicado en Transl Androl Urol (2019)

Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue

por Kolijn, Kimberley, van Leenders, Geert J. L. H.
Publicado en BMC Res Notes (2016)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer

por Kolijn, Kimberley, Verhoef, Esther I., van Leenders, Geert J.L.H.
Publicado en Oncotarget (2015)

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading

por van Leenders, Geert J L H, Verhoef, Esther I, Hollemans, Eva
Publicado en Histopathology (2020)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review

por Hoogland, A. Marije, Kweldam, Charlotte F., van Leenders, Geert J. L. H.
Publicado 2014

Multi-line fluorescence scanning microscope for multi-focal imaging with unlimited field of view

por van der Graaff, Leon, van Leenders, Geert J. L. H., Boyaval, Fanny, Stallinga, Sjoerd
Publicado en Biomed Opt Express (2019)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer

por Hoogland, A. Marije, Böttcher, René, Verhoef, Esther, Jenster, Guido, van Leenders, Geert J.L.H.
Publicado en Oncotarget (2016)

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study

por Campos, Anna K., Hoving, Hilde D., Rosati, Stefano, van Leenders, Geert J. L. H., de Jong, Igle J.
Publicado en Int J Mol Sci (2016)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

por Beukers, Willemien, Meijer, Titia, Vissers, Cornelis J., Boormans, Joost L., Zwarthoff, Ellen C., van Leenders, Geert J. L. H.
Publicado 2012

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis

por Hollemans, Eva, Verhoef, Esther I., Bangma, Chris H., Rietbergen, John, Helleman, Jozien, Roobol, Monique J., van Leenders, Geert J.L.H.
Publicado en Mod Pathol (2018)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Rietbergen, John, Roobol, Monique J, Helleman, Jozien, van Leenders, Geert J L H
Publicado en Histopathology (2020)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Schoots, Ivo, Rietbergen, John, Helleman, Jozien, Roobol, Monique J, van Leenders, Geert J L H
Publicado en Histopathology (2019)

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma

por Stelloo, Suzan, Sanders, Joyce, Nevedomskaya, Ekaterina, de Jong, Jeroen, Peters, Dennis, van Leenders, Geert J.L.H., Jenster, Guido, Bergman, Andries M., Zwart, Wilbert
Publicado en Oncotarget (2016)

Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy

por van Leenders, Geert J. L. H., Gage, Wesley R., Hicks, Jessica L., van Balken, Bianca, Aalders, Tilly W., Schalken, Jack A., De Marzo, Angelo M.
Publicado 2003

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer

por Böttcher, René, Hoogland, A. Marije, Dits, Natasja, Verhoef, Esther I., Kweldam, Charlotte, Waranecki, Piotr, Bangma, Chris H., van Leenders, Geert J.L.H., Jenster, Guido
Publicado en Oncotarget (2015)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies

por Osses, Daniël F., Arsov, Christian, Schimmöller, Lars, Schoots, Ivo G., van Leenders, Geert J.L.H., Esposito, Irene, Remmers, Sebastiaan, Albers, Peter, Roobol, Monique J.
Publicado en J Pers Med (2020)

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases

por Böttcher, René, Dulla, Kalyan, van Strijp, Dianne, Dits, Natasja, Verhoef, Esther I., Baillie, George S., van Leenders, Geert J.L.H., Houslay, Miles D., Jenster, Guido, Hoffmann, Ralf
Publicado en Oncotarget (2016)

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome

por van der Slot, Margaretha A., Hollemans, Eva, den Bakker, Michael A., Hoedemaeker, Robert, Kliffen, Mike, Budel, Leo M., Goemaere, Natascha N. T., van Leenders, Geert J. L. H.
Publicado en Virchows Arch (2020)

Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer

por van Leenders, Geert J. L. H., Sookhlall, Rajesh, Teubel, Wilma J., de Ridder, Corrina M. A., Reneman, Suzanne, Sacchetti, Andrea, Vissers, Kees J., van Weerden, Wytske, Jenster, Guido
Publicado 2011

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant...

por Schoots, Ivo G., Osses, Daniel F., Drost, Frank-Jan H., Verbeek, Jan F. M., Remmers, Sebastiaan, van Leenders, Geert J. L. H., Bangma, Chris H., Roobol, Monique J.
Publicado en Transl Androl Urol (2018)